Ads
-
Related paper
- BLOCKADE OF THE CYTOKINE STORM IN SEVERE SARS-COV-2 INFECTION: DRUG SUPPRESSION OR EXTRACORPOREAL ELIMINATION?
- THE USE OF ANTI-CYTOKINE PROPERTIES OF THE DOMESTIC HEMOSORBENT HEMO-PROTEASOSORB IN CYTOKINE STORM IN PATIENTS WITH SEVERE COVID-19
- Severe herpes-simplex-virus-1-reactivation during severe SARS-CoV-2 infection
- A CLINICAL CASE OF SEVERE COVID-19 INFECTION IN A PUERPERANT IN THE EARLY POSTPARTUM PERIOD USING EXTRACORPOREAL MEMBRANE OXYGENATION
- SARS-CoV-2-Infection in Children and Newborn: Less Severe Than in Adults? |Biomedgrid
- EFFECT OF HEMOSORPTION WITH EXTRACORPOREAL AUTOHEMOMAGNETIC THERAPY VERSUS DRUG THERAPY WITH IL-6 RECEPTOR ANTAGONISTS ON CLINICAL AND LABORATORY PARAMETERS OF PATIENTS WITH SEVERE COVID-19
- Can Warm, Humidified High-Flow Filtered Air Therapy Be Protective Against Severe Infection from Sars-Cov-2 and Other Respiratory Pathogens? |Biomedgrid
- Cytokine Storm in COVID-19
- Current and Future Challenges In Drug Therapeutics for Sars-Cov-2 Infection in Covid-19 Pandemic |Biomedgrid
- Targeting "Cytokine Storm" for Therapeutic Benefit in COVID19 Patients